Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
Construction Bids
home | Welcome, sign in or click here to subscribe. | login |
September 17, 2019
BOSTON — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity.
Whether the company can pull it off remains to be seen, especially with about half the states opposed to the deal.
. . .